JPWO2022154037A1 - - Google Patents
Info
- Publication number
- JPWO2022154037A1 JPWO2022154037A1 JP2022575623A JP2022575623A JPWO2022154037A1 JP WO2022154037 A1 JPWO2022154037 A1 JP WO2022154037A1 JP 2022575623 A JP2022575623 A JP 2022575623A JP 2022575623 A JP2022575623 A JP 2022575623A JP WO2022154037 A1 JPWO2022154037 A1 JP WO2022154037A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021004066 | 2021-01-14 | ||
| PCT/JP2022/000848 WO2022154037A1 (ja) | 2021-01-14 | 2022-01-13 | がんの予後バイオマーカー |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022154037A1 true JPWO2022154037A1 (enrdf_load_stackoverflow) | 2022-07-21 |
Family
ID=82446336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575623A Pending JPWO2022154037A1 (enrdf_load_stackoverflow) | 2021-01-14 | 2022-01-13 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022154037A1 (enrdf_load_stackoverflow) |
| WO (1) | WO2022154037A1 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024233786A1 (en) * | 2023-03-03 | 2025-08-28 | Karydo Therapeutix, Inc. | Antibody or antigen-binding fragment thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ624816A (en) * | 2009-01-14 | 2015-07-31 | Us Health | Ratio based biomarkers and methods of use thereof |
| JP2013245960A (ja) * | 2012-05-23 | 2013-12-09 | National Institute Of Biomedical Innovation | 乳がん患者手術治療後の予後判定方法 |
| GB201314485D0 (en) * | 2013-08-13 | 2013-09-25 | Electrophoretics Ltd | Materials and methods relating to pancreatic cancer |
-
2022
- 2022-01-13 JP JP2022575623A patent/JPWO2022154037A1/ja active Pending
- 2022-01-13 WO PCT/JP2022/000848 patent/WO2022154037A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022154037A1 (ja) | 2022-07-21 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241129 |